Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03981198 · ClinicalTrials.gov registry record · NA
Proof of Concept (POC) Study of the Soliton Rapid Acoustic (RAP) for the Treatment of Cellulite
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03981198 is a NA study that has completed, run by Soliton. The registered enrollment target is 10 participants.
The verdict
NCT03981198, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Feasibility study is to evaluate the safety, tolerability and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the treatment of cellulite
Interventions
- DEVICE Soliton Rapid Acoustic Pulse (RAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2019-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03981198
The ClinicalTrials.gov registry entry for NCT03981198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soliton Rapid Acoustic Pulse (RAP) is the first listed.
NCT03981198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03981198 about?
NCT03981198 is a clinical study titled "Proof of Concept (POC) Study of the Soliton Rapid Acoustic (RAP) for the Treatment of Cellulite". Feasibility study is to evaluate the safety, tolerability and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the treatment of cellulite
What is the current status of trial NCT03981198?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-31. Estimated completion is 2019-08-05.
What interventions are being tested in trial NCT03981198?
The interventions under investigation include: Soliton Rapid Acoustic Pulse (RAP) (DEVICE).
Who is sponsoring clinical trial NCT03981198?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.